PDB: 157 resultsInfo pagesStatus searchChemie searchBIRD

---

2LZG	NMR Structure of Mdm2 (6-125) with Pip-1 Descriptor: E3 ubiquitin-protein ligase Mdm2, [(3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-(cyclopropylmethyl)-2-oxopiperidin-3-yl]acetic acid Authors: Michelsen, K.B, Jordan, J.B, Lewis, J, Long, A.M, Yang, E, Rew, Y, Zhou, J, Yakowec, P, Schnier, P.D, Huang, X, Poppe, L. Deposit date: 2012-10-02 Release date: 2012-11-07 Last modified: 2024-05-01 Method: SOLUTION NMR Cite: Ordering of the N-Terminus of Human MDM2 by Small Molecule Inhibitors. J.Am.Chem.Soc., 134, 2012
2M86	Solution structure of Hdm2 with engineered cyclotide Descriptor: E3 ubiquitin-protein ligase Mdm2, MCo-PMI Authors: Majumder, S, Ji, Y, Millard, M, Borra, R, Bi, T, Elnagar, A.Y, Neamati, N, Camarero, J.A. Deposit date: 2013-05-07 Release date: 2013-07-31 Last modified: 2023-06-14 Method: SOLUTION NMR Cite: In Vivo Activation of the p53 Tumor Suppressor Pathway by an Engineered Cyclotide. J.Am.Chem.Soc., 135, 2013
4UMN	Structure of a stapled peptide antagonist bound to Nutlin-resistant Mdm2. Descriptor: E3 ubiquitin-protein ligase Mdm2, M06 Authors: Chee, S, Wongsantichon, J, Quah, S, Robinson, R.C, Verma, C, Lane, D.P, Brown, C.J, Ghadessy, F.J. Deposit date: 2014-05-20 Release date: 2014-05-28 Last modified: 2024-02-07 Method: X-RAY DIFFRACTION (1.99 Å) Cite: Structure of a stapled peptide antagonist bound to nutlin-resistant Mdm2. PLoS ONE, 9, 2014
4UD7	Structure of the stapled peptide YS-02 bound to MDM2 Descriptor: MDM2, YS-02 Authors: Tan, Y.S, Reeks, J, Brown, C.J, Jennings, C.E, Eapen, R.S, Tng, Q.S, Thean, D, Ying, Y.T, Gago, F.J.F, Lane, D.P, Noble, M.E.M, Verma, C. Deposit date: 2014-12-08 Release date: 2016-01-13 Last modified: 2023-12-20 Method: X-RAY DIFFRACTION (1.6 Å) Cite: Benzene Probes in Molecular Dynamics Simulations Reveal Novel Binding Sites for Ligand Design. J Phys Chem Lett, 7, 2016
4UE1	Structure of the stapled peptide YS-01 bound to MDM2 Descriptor: E3 UBIQUITIN-PROTEIN LIGASE MDM2, YS-01 Authors: Tan, Y.S, Reeks, J, Brown, C.J, Jennings, C.E, Eapen, R.S, Tng, Q.S, Thean, D, Ying, Y.T, Gago, F.J.F, Lane, D.P, Noble, M.E.M, Verma, C. Deposit date: 2014-12-14 Release date: 2016-01-13 Last modified: 2023-12-20 Method: X-RAY DIFFRACTION (1.45 Å) Cite: Benzene Probes in Molecular Dynamics Simulations Reveal Novel Binding Sites for Ligand Design. J Phys Chem Lett, 7, 2016
5XXK	Structure-activity studies of Mdm2/Mdm4-binding stapled peptides comprising non-natural amino acids Descriptor: E3 ubiquitin-protein ligase Mdm2, Hydrocarbon stapled peptide THC-SER-PHE-0EH-GLU-TYR-6CW-ALA-LEU-LEU-MK8-NH2 Authors: Brown, C.J. Deposit date: 2017-07-04 Release date: 2017-12-27 Last modified: 2023-11-22 Method: X-RAY DIFFRACTION (1.66 Å) Cite: Structure-activity studies of Mdm2/Mdm4-binding stapled peptides comprising non-natural amino acids. PLoS ONE, 12, 2017
6KZU	Macrocyclization of an all-D linear peptide improves target affinity and imparts cellular activity: A novel stapled alpha-helical peptide modality Descriptor: 2JN-DAL-E03-DTY-2JN-DSG-TDF-DGL-MK8-DLE-DLE-2JN, E3 ubiquitin-protein ligase Mdm2 Authors: Jiang, S, Brown, C.J. Deposit date: 2019-09-25 Release date: 2019-10-16 Last modified: 2023-11-22 Method: X-RAY DIFFRACTION (1.79 Å) Cite: Macrocyclization of an all-d linear alpha-helical peptide imparts cellular permeability. Chem Sci, 11, 2020
5WTS	Green fluorescent protein linked MTide-02 inhibitor in complex with mdm2 Descriptor: E3 ubiquitin-protein ligase Mdm2, GLYCEROL, Green fluorescent protein linked MTide-02, ... Authors: Wongsantichon, J, Robinson, R.C, Ghadessy, F.J. Deposit date: 2016-12-14 Release date: 2017-12-20 Last modified: 2020-11-25 Method: X-RAY DIFFRACTION (3.004 Å) Cite: Green fluorescent protein linked peptide inhibitor PMI in complex with mdm2 To Be Published
4ERF	crystal structure of MDM2 (17-111) in complex with compound 29 (AM-8553) Descriptor: E3 ubiquitin-protein ligase Mdm2, {(3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-[(2S,3S)-2-hydroxypentan-3-yl]-3-methyl-2-oxopiperidin-3-yl}acetic acid Authors: Huang, X. Deposit date: 2012-04-20 Release date: 2012-05-23 Last modified: 2024-02-28 Method: X-RAY DIFFRACTION (2 Å) Cite: Structure-based design of novel inhibitors of the MDM2-p53 interaction. J.Med.Chem., 55, 2012
3TJ2	Structure of a novel submicromolar MDM2 inhibitor Descriptor: 3-{(1S)-2-(tert-butylamino)-1-[(4-chlorobenzyl)(formyl)amino]-2-oxoethyl}-6-chloro-1H-indole-2-carboxylic acid, E3 ubiquitin-protein ligase Mdm2, POTASSIUM ION Authors: Wolf, S, Huang, Y, Popowicz, G.M, Goda, S, Holak, T.A, Doemling, A. Deposit date: 2011-08-23 Release date: 2012-09-12 Last modified: 2023-09-13 Method: X-RAY DIFFRACTION (2.1 Å) Cite: Ugi Multicomponent Reaction Derived p53-Mdm2 Antagonists To be published
4ERE	crystal structure of MDM2 (17-111) in complex with compound 23 Descriptor: E3 ubiquitin-protein ligase Mdm2, SULFATE ION, [(3R,5R,6S)-1-[(2S)-1-tert-butoxy-1-oxobutan-2-yl]-5-(3-chlorophenyl)-6-(4-chlorophenyl)-2-oxopiperidin-3-yl]acetic acid Authors: Huang, X. Deposit date: 2012-04-20 Release date: 2012-05-23 Last modified: 2024-02-28 Method: X-RAY DIFFRACTION (1.8 Å) Cite: Structure-based design of novel inhibitors of the MDM2-p53 interaction. J.Med.Chem., 55, 2012
4DIJ	The Central Valine Concept Provides an Entry in a New Class of Non Peptide Inhibitors of the P53-MDM2 Interaction Descriptor: 6-chloro-3-[1-(4-chlorobenzyl)-4-phenyl-1H-imidazol-5-yl]-N-[2-(morpholin-4-yl)ethyl]-1H-indole-2-carboxamide, E3 ubiquitin-protein ligase Mdm2 Authors: Kallen, J. Deposit date: 2012-01-31 Release date: 2012-05-02 Last modified: 2024-04-03 Method: X-RAY DIFFRACTION (1.9 Å) Cite: The central valine concept provides an entry in a new class of non peptide inhibitors of the p53-MDM2 interaction. Bioorg.Med.Chem.Lett., 22, 2012
3TPX	Crystal structure of human MDM2 in complex with a trifluoromethylated D-peptide inhibitor Descriptor: ACETATE ION, CHLORIDE ION, D-peptide inhibitor DPMI-delta, ... Authors: Wu, X, Pazgier, M. Deposit date: 2011-09-08 Release date: 2012-06-20 Last modified: 2023-12-06 Method: X-RAY DIFFRACTION (1.8 Å) Cite: An Ultrahigh Affinity d-Peptide Antagonist Of MDM2. J.Med.Chem., 55, 2012
6T2E	Multicomponent Peptide Stapling as a Diversity-Driven Tool for the Development of Inhibitors of Protein-Protein Interactions Descriptor: E3 ubiquitin-protein ligase Mdm2, Stapled peptide GAR300-Gm Authors: Groves, R.M, Ali, M.A, Atmaj, J, van Oosterwijk, N, Domling, A, Rivera, G.D, Ricardo, G.M. Deposit date: 2019-10-08 Release date: 2020-01-29 Last modified: 2024-01-24 Method: X-RAY DIFFRACTION (2.4 Å) Cite: Multicomponent Peptide Stapling as a Diversity-Driven Tool for the Development of Inhibitors of Protein-Protein Interactions. Angew.Chem.Int.Ed.Engl., 59, 2020
6T2F	Multicomponent Peptide Stapling as a Diversity-Driven Tool for the Development of Inhibitors of Protein-Protein Interactions Descriptor: 2-(methylamino)-~{N}-[[3-[[2-(methylamino)ethanoylamino]methyl]phenyl]methyl]ethanamide, E3 ubiquitin-protein ligase Mdm2, MDM2 in complex with GAR300-Am Authors: Groves, R.M, Ali, M.A, Atmaj, J, van Oosterwijk, N, Domling, A, Rivera, G.D, Ricardo, G.M. Deposit date: 2019-10-08 Release date: 2020-01-29 Last modified: 2024-01-24 Method: X-RAY DIFFRACTION (2.09 Å) Cite: Multicomponent Peptide Stapling as a Diversity-Driven Tool for the Development of Inhibitors of Protein-Protein Interactions. Angew.Chem.Int.Ed.Engl., 59, 2020
6T2D	Multicomponent Peptide Stapling as a Diversity-Driven Tool for the Development of Inhibitors of Protein-Protein Interactions Descriptor: 2-(methylamino)-~{N}-[[4-[[2-(methylamino)ethanoylamino]methyl]phenyl]methyl]ethanamide, 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID, DIMETHYL SULFOXIDE, ... Authors: Groves, R.M, Ali, M.A, Atmaj, J, van Oosterwijk, N, Domling, A, Rivera, G.D, Ricardo, G.M. Deposit date: 2019-10-08 Release date: 2020-01-29 Last modified: 2024-01-24 Method: X-RAY DIFFRACTION (1.8 Å) Cite: Multicomponent Peptide Stapling as a Diversity-Driven Tool for the Development of Inhibitors of Protein-Protein Interactions. Angew.Chem.Int.Ed.Engl., 59, 2020
5Z02	Crystal structure of HIS6-tagged Mdm2 with nutlin-3a Descriptor: 4-({(4S,5R)-4,5-bis(4-chlorophenyl)-2-[4-methoxy-2-(propan-2-yloxy)phenyl]-4,5-dihydro-1H-imidazol-1-yl}carbonyl)piperazin-2-one, E3 ubiquitin-protein ligase Mdm2 Authors: Su, Z.D, Cheng, X.Y, Chen, R, Pi, N. Deposit date: 2017-12-18 Release date: 2018-01-03 Last modified: 2023-11-22 Method: X-RAY DIFFRACTION (1.35 Å) Cite: Crystal structure of HIS6-tagged Mdm2 with nutlin-3a to be published
3TU1	Exhaustive Fluorine Scanning towards Potent p53-MDM2 Antagonist Descriptor: 3-[(1S)-2-(tert-butylamino)-1-{N-[(3,4-difluorophenyl)methyl]formamido}-2-oxoethyl]-6-chloro-1H-indole-2-carboxylic acid, E3 ubiquitin-protein ligase Mdm2 Authors: Wolf, S, Huang, Y, Koes, D, Popowicz, G.M, Camacho, C.J, Holak, T.A, Doemling, A. Deposit date: 2011-09-15 Release date: 2011-11-02 Last modified: 2024-05-29 Method: X-RAY DIFFRACTION (1.603 Å) Cite: Exhaustive Fluorine Scanning toward Potent p53-Mdm2 Antagonists. Chemmedchem, 7, 2012
6Q9L	HDM2 (17-111, WILDTYPE) COMPLEXED WITH COMPOUND 9 AT 1.13A; Structural states of Hdm2 and HdmX: X-ray elucidation of adaptations and binding interactions for different chemical compound classes Descriptor: CHLORIDE ION, E3 ubiquitin-protein ligase Mdm2, [6-chloranyl-3-[3-[[4-chloranyl-2-(hydroxymethyl)phenyl]methyl]-5-phenyl-imidazol-4-yl]-1~{H}-indol-2-yl]-[(3~{S})-3-[3-(dimethylamino)propyl-methyl-amino]pyrrolidin-1-yl]methanone Authors: Kallen, J. Deposit date: 2018-12-18 Release date: 2019-05-15 Last modified: 2024-01-24 Method: X-RAY DIFFRACTION (1.13 Å) Cite: Structural States of Hdm2 and HdmX: X-ray Elucidation of Adaptations and Binding Interactions for Different Chemical Compound Classes. Chemmedchem, 14, 2019
6Q9O	HDM2 (17-111, WILDTYPE) COMPLEXED WITH COMPOUND 10 AT 1.21A; Structural states of Hdm2 and HdmX: X-ray elucidation of adaptations and binding interactions for different chemical compound classes Descriptor: E3 ubiquitin-protein ligase Mdm2, ~{N}-~{tert}-butyl-2-[4-chloranyl-2-[5-(3-chloranyl-4-fluoranyl-phenyl)-2-cyclohexyl-4-(1~{H}-1,2,3,4-tetrazol-5-yl)imidazol-1-yl]phenyl]ethanamide Authors: Kallen, J. Deposit date: 2018-12-18 Release date: 2019-05-15 Last modified: 2024-01-24 Method: X-RAY DIFFRACTION (1.21 Å) Cite: Structural States of Hdm2 and HdmX: X-ray Elucidation of Adaptations and Binding Interactions for Different Chemical Compound Classes. Chemmedchem, 14, 2019
6Q9H	HDM2 (17-111, WILD TYPE) COMPLEXED WITH COMPOUND 11 AT 2.0A; Structural states of Hdm2 and HdmX: X-ray elucidation of adaptations and binding interactions for different chemical compound classes Descriptor: (4~{S})-5-(3-chloranyl-2-fluoranyl-phenyl)-4-(4-chloranyl-2-methyl-phenyl)-3-propan-2-yl-1,4-dihydropyrrolo[3,4-c]pyrazol-6-one, E3 ubiquitin-protein ligase Mdm2 Authors: Kallen, J. Deposit date: 2018-12-18 Release date: 2019-05-15 Last modified: 2024-01-24 Method: X-RAY DIFFRACTION (2 Å) Cite: Structural States of Hdm2 and HdmX: X-ray Elucidation of Adaptations and Binding Interactions for Different Chemical Compound Classes. Chemmedchem, 14, 2019
3VBG	Structure of hDM2 with Dimer Inducing Indolyl Hydantoin RO-2443 Descriptor: (5Z)-5-[(6-chloro-7-methyl-1H-indol-3-yl)methylidene]-3-(3,4-difluorobenzyl)imidazolidine-2,4-dione, E3 ubiquitin-protein ligase Mdm2 Authors: Lukacs, C.M, Janson, C.A, Graves, B.J. Deposit date: 2012-01-02 Release date: 2012-06-27 Last modified: 2023-09-13 Method: X-RAY DIFFRACTION (2.8 Å) Cite: Activation of the p53 pathway by small-molecule-induced MDM2 and MDMX dimerization. Proc.Natl.Acad.Sci.USA, 109, 2012
6Q96	HDM2 (17-111, WILD TYPE) COMPLEXED WITH COMPOUND 12 AT 1.8A; Structural states of Hdm2 and HdmX: X-ray elucidation of adaptations and binding interactions for different chemical compound classes Descriptor: 4-[(4~{S})-5-(5-chloranyl-2-oxidanylidene-1~{H}-pyridin-3-yl)-2-[2-(dimethylamino)-4-methoxy-pyrimidin-5-yl]-6-oxidanylidene-3-propan-2-yl-4~{H}-pyrrolo[3,4-c]pyrazol-4-yl]benzenecarbonitrile, E3 ubiquitin-protein ligase Mdm2, SULFATE ION Authors: Kallen, J. Deposit date: 2018-12-17 Release date: 2019-05-15 Last modified: 2024-01-24 Method: X-RAY DIFFRACTION (1.8 Å) Cite: Structural States of Hdm2 and HdmX: X-ray Elucidation of Adaptations and Binding Interactions for Different Chemical Compound Classes. Chemmedchem, 14, 2019
3VZV	Crystal structure of human mdm2 with a dihydroimidazothiazole inhibitor Descriptor: 1-{[(5R,6S)-5,6-bis(4-chlorophenyl)-6-methyl-3-(propan-2-yl)-5,6-dihydroimidazo[2,1-b][1,3]thiazol-2-yl]carbonyl}-N,N-dimethyl-L-prolinamide, E3 ubiquitin-protein ligase Mdm2 Authors: Shimizu, H, Katakura, S, Miyazaki, M, Naito, H, Sugimoto, Y, Kawato, H, Okayama, T, Soga, T. Deposit date: 2012-10-16 Release date: 2013-02-06 Last modified: 2024-03-20 Method: X-RAY DIFFRACTION (2.8 Å) Cite: Lead optimization of novel p53-MDM2 interaction inhibitors possessing dihydroimidazothiazole scaffold Bioorg.Med.Chem.Lett., 23, 2013
5TRF	MDM2 in complex with SAR405838 Descriptor: (2'S,3R,4'S,5'R)-6-chloro-4'-(3-chloro-2-fluorophenyl)-2'-(2,2-dimethylpropyl)-N-(trans-4-hydroxycyclohexyl)-2-oxo-1,2-dihydrospiro[indole-3,3'-pyrrolidine]-5'-carboxamide, E3 ubiquitin-protein ligase Mdm2, GLYCEROL, ... Authors: Meagher, J.L, Stuckey, J.A. Deposit date: 2016-10-26 Release date: 2016-11-09 Last modified: 2024-03-06 Method: X-RAY DIFFRACTION (2.1 Å) Cite: SAR405838: an optimized inhibitor of MDM2-p53 interaction that induces complete and durable tumor regression. Cancer Res., 74, 2014

<1234567>